Gaspard Pardon is the Head of the Bioengineering and Organoids Technology platform at the AGORA Cancer Center Lausanne. In this role, he is establishing a platform that bridges translational bioengineering and interdisciplinary research. The platform facilitates translational biomedical research by integrating cutting-edge technologies from EPFL and the broader engineering community. It also supports the development of innovative assays and technologies by offering access to clinical research expertise, resources, and infrastructure.